Japanese Orthopedic Biomaterials Market
London (PRWEB) September 25, 2013 -- The Japanese orthopedic biomaterials market is expected to approach $1.5 billion by 2019. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Japanese orthopedic biomaterials market.
The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented only into synthetics) and hyaluronic acid (HA) viscosupplementation. Although the market has reached maturity in Japan, it is expected to continue to grow as a result of the large aging population. Further growth in the overall market will be fuelled by the increased value of the HA viscosupplementation segment. This is due to the continued use of premium priced three-injection cycle products in Japan that were introduced in December 2010.
Scope:
This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.
Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment & Country
Trend Analysis by Segment & Country
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring
Main Markets Included:
Bone Graft Substitute
Hyaluronic Acid Viscosupplementation
Sub-Segments Included:
Autograft
Non-Proprietary Allograft
Synthetic Allograft
Demineralized Bone Matrix
Cervical Spine
Thoracolumbar Spine
Trauma & Reconstruction
Craniomaxillofacial
Single-injection products
Three-injection cycle products
Five-injection cycle products
Companies Included:
Seikagaku (Kaken)
Chugai Genzyme (Teijin)
Maruho
Meiji Seika Kaisha
Taisho
Olympus Terumo
Hoya/Pentax
Japan Medicalnext
Kyocera Medical
Others Include:
Biomet, JMDM, Mizuho, NGKNTK, Stryker, Zimmer and local Japanese pharmaceutical
companies.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
1.1 JAPAN MARKET FOR ORTHOPEDIC BIOMATERIALS 1
1.2 GROWTH TRENDS BY SEGMENT 2
1.3 BONE GRAFT SUBSTITUTE MARKET 3
1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 4
1.5 COMPETITIVE ANALYSIS 5
RESEARCH METHODOLOGY 6
2.1 RESEARCH SCOPE 6
2.2 IDATA’S 9-STEP METHODOLOGY 6
Step 1: Project Initiation & Team Selection 7
Step 2: Prepare Data Systems and Perform Secondary Research 9
Step 3: Preparation for Interviews & Questionnaire Design 10
Step 4: Performing Primary Research 11
Step 5: Research Analysis: Establishing Baseline Estimates 13
Step 6: Market Forecast and Analysis 14
Step 7: Identify Strategic Opportunities 16
Step 8: Final Review and Market Release 17
Step 9: Customer Feedback and Market Monitoring 17
JAPANESE ORTHOPEDIC BIOMATERIALS MARKET 18
3.1 INTRODUCTION 18
3.1.1 Growth Factors 18
3.1.2 Bone Graft Substitutes 19
3.1.3 Hyaluronic Acid Viscosupplementation 19
3.2 CURRENCY EXCHANGE RATE 20
3.3 PROCEDURES 21
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Segment 21
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Indication 23
3.3.3 Bone Graft Substitute Procedures 25
3.3.4 Hyaluronic Acid Viscosupplementation Procedures 26
3.4 MARKET OVERVIEW 27
3.5 TREND ANALYSIS 31
3.6 MARKET DRIVERS AND LIMITERS 33
3.6.1 Market Drivers 33
3.6.2 Market Limiters 33
3.7 COMPETITIVE ANALYSIS 35
3.7.1 Leading Competitors 35
3.8 MERGERS AND ACQUISITIONS 39
BONE GRAFT SUBSTITUTE MARKET 40
4.1 INTRODUCTION 40
4.1.1.1 Autograft 41
4.1.1.2 Non-Proprietary Allograft 41
4.1.1.3 Demineralized Bone Matrix 41
4.1.1.4 Synthetic 42
4.1.2 Volumes Represented per Procedure 43
4.2 MARKET OVERVIEW 44
4.3 MARKET ANALYSIS & FORECAST 46
4.3.1 Bone Graft Substitute Market by Material 46
4.3.1.1 Synthetic Market 47
4.3.2 Bone Graft Substitute Market by Indication 48
4.3.2.1 Cervical Spine Market 52
4.3.2.2 Thoracolumbar Spine Market 53
4.3.2.3 Trauma & Reconstruction Market 54
4.3.2.4 Craniomaxillofacial Market 55
4.4 DRIVERS AND LIMITERS 56
4.4.1 Market Drivers 56
4.4.2 Market Limiters 56
4.5 COMPETITIVE ANALYSIS 58
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 60
5.1 INTRODUCTION 60
5.1.1.1 Single-Injection Products 61
5.1.1.2 Three-Injection Cycle Products 61
5.1.1.3 Five-Injection Cycle Products 61
5.2 MARKET OVERVIEW 62
5.2.1 Hyaluronic Acid (HA) Viscosupplementation Market by Segment 62
5.3 MARKET ANALYSIS & FORECAST 67
5.3.1.1 Three-Injection Cycle Market 67
5.3.1.2 Five-Injection Cycle Market 68
5.4 DRIVERS AND LIMITERS 69
5.4.1 Market Drivers 69
5.4.2 Market Limiters 70
5.5 COMPETITIVE ANALYSIS 71
ABBREVIATIONS 74
Read the full report:
Japanese Orthopedic Biomaterials Market
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com
Sarah Smith, Research Advisor at Reportbuyer.com, +44 208 816 85 48, [email protected]
Share this article